Case Laws
Acts
Notifications
Circulars
Classification
Forms
Manuals
Articles
News
D. Forum
Highlights
Notes
🚨 Important Update for Our Users
We are transitioning to our new and improved portal - www.taxtmi.com - for a better experience.
⚠️ This portal will be discontinued on 31-07-2025
If you encounter any issues or problems while using the new portal,
please
let us know via our feedback form
so we can address them promptly.
Home
2018 (12) TMI 2005 - SCH - Service TaxBusiness Support Services - testing and analysis of newly developed drugs on human participants - Exemption under Notification 11/2007-ST - Qualification for export of service criteria - As decided by CESTAT 2018 (2) TMI 1681 - CESTAT NEW DELHI activities are initiation of trial sites monitoring trial monitoring site management query response and coordinate with M/s Merck USA etc. Perusal of these details clearly reveal that the appellant are directly engaged in the activities of conducting clinical trial studies. They did obtain no objection approval from the concerned drug authorities in India. In the face of such factual details we find that the findings recorded in the impugned order is neither factually nor legally tenable. The appellants activities are clearly covered by the exemption under Notification 11/2007-ST dated 01/03/2007. HELD THAT - Delay condoned. Admit.
|